Development of RNA Base Editing Technologies for Precision Medicines with Axiomer® and Trident® presented at TIDES USA 2022 by Gerard Platenburg - ProQR Therapeutics.
… its clinical stage pipeline programs and the Axiomer ® RNA editing platform. ProQR leadership will highlight key … design and assumptions. The QR-421a, QR-1123, QR-504a, and RNA editing platform technologies will also be featured. …
… Operating and Financial Results Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, … RNA therapies based on its proprietary Axiomer RNA editing technology platform, today reported its financial …
… RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced that it will … Therapeutics II Poster Presentations Title: ADAR-Mediated RNA Editing-Based Correction of PNPLA3 I148M Functionality to …
